GGrantIndex
← Search

SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72

$182,902N01FY2023DANIH

Irisys, Inc., San Diego CA

Investigators

Abstract

The scope of this contract is for formulation development of a solid oral dosage form as tablets, validation of analytical methods on drug products, manufacture of pilot batches, GMP drug product for a phase I clinical trial, and long term stability study under ICH guideline.

View original record on NIH RePORTER →